Skip to content

Philip T. Sager, MD

NPI 1427487149ActiveIndividual· Internal Medicine, Cardiovascular Disease· San Francisco, CA

Internal Medicine, Cardiovascular Disease (MD) in San Francisco, California, licensed in CA, with an NPI issued in November 2013. Syndax Pharmaceuticals, Inc. was the largest of 3 companies reporting payments in 2025, $158,025 in all, mostly consulting fees.

Overview

NPI1427487149
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedNov 4, 2013
Last updated in NPPESNov 4, 2013

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Cardiovascular Disease Primary207RC0000XG62729CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$158,025 · 7 payments from 3 companies
  • 2024$28,520 · 5 payments from 3 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$158,025 · 7 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other cardiologists in San Francisco

All 159 cardiologists in San Francisco · All cardiologists in California